జర్నల్ ఆఫ్ ప్లాంట్ జెనెటిక్స్ అండ్ బ్రీడింగ్

నైరూప్య

Preclinical study of the effect of endocannabinoid compounds on the treatment of sleep disorders

Del Potter

ZBN Research is engaged in preclinical studies of indications of insomnia and pain relief using novel formulations that include ancillary “entourage” compounds and ligands, combinations of cannabinoids, modified THC analogues and new transdermal and sublingual delivery systems that shorten the time to onset of effects and allow for sustained delivery of formulations. Recent findings from ZBN Research’s preclinical study of the effect of endocannabinoid compounds on the treatment of sleep disorders indicate the effectiveness of its new formulation compared to conventional sleep medications.